トップページ > 各部紹介 > データサイエンス研究部 > 業績論文

業績論文

2024年

 英文

      1. Momosaka T, Saito J, Otsuki A, Katanoda K, et al. Associations of individual characteristics and socioeconomic status with heated tobacco product harmfulness perceptions in Japan: A nationwide cross-sectional study (INFORM Study 2020). J Epidemiol. Published online January 6, 2024.[PubMed]

2023年

 英文

      1. Schüz J, Ostroumova E, Kesminiene A, Davies L, Ahn HS, Togawa K, Vaccarella S. Response to Toshihide Tsuda, Yumiko Miyano and Eiji Yamamoto. Environ Health. 2023 Jan 26;22(1):13.[PubMed]
      2. Tanaka H, Mackenbach JP, Kobayashi Y. Estimation of socioeconomic inequalities in mortality in Japan using national census-linked longitudinal mortality data. J Epidemiol. 2023;33(5):246-255.[PubMed]
      3. Tanaka H, Tanaka S, Togawa K, Katanoda K. Practical implications of the update to the 2015 Japan Standard Population: mortality archive from 1950 to 2020 in Japan. J Epidemiol.2023;33(7):372-380.[PubMed]
      4. Mitsutake S, Takahashi Y, Otsuki A, et al. Chronic Diseases and Sociodemographic Characteristics Associated With Online Health Information Seeking and Using Social Networking Sites: Nationally Representative Cross-sectional Survey in Japan. J Med Internet Res. 2023;25:e44741. Published 2023 Mar 2. [PubMed]
      5. Goto A, Katanoda K. Should We Acknowledge ChatGPT as an Author?. J Epidemiol. 2023;33(7):333-334.[PubMed]
      6. Minami T, Inoue M, Tabuchi T, Katanoda K. Voluntary suspension of medically-assisted reproduction during the COVID-19 pandemic in Japan: a nationwide internet survey. Hum Fertil (Camb). 2023;26(1):169-181.[PubMed]
      7. Charvat H, Fukui K, Matsuda T, Katanoda K, Ito Y. Impact of cancer and other causes of death on mortality of cancer patients: A study based on Japanese population-based registry data. Int J Cancer. 2023;153(6):1162-1171.[PubMed]
      8. Katanoda K, Tanaka H, Tanaka S, Togawa K. Toward Better Utilization of the 2015 Japan Standard Population. J Epidemiol. 2023;33(10):545.[PubMed]
      9. Sugiyama T, Yanagisawa-Sugita A, Tanaka H, et al. Different incidences of diabetic retinopathy requiring treatment since diagnosis according to the course of diabetes diagnosis: a retrospective cohort study. Sci Rep. 2023;13(1):10527. Published 2023 Jun 29.[PubMed]
      10. Nakata K, Matsuda T, Hori M, Sugiyama H, Tabuchi K, Miyashiro I, Matsumoto K, Yoneda A, Takita J, Shimizu C, Katanoda K. Cancer incidence and type of treatment hospital among children, adolescents, and young adults in Japan, 2016-2018. Cancer Sci. 2023;114(9):3770-3782.[PubMed]
      11. Usui Y, Ito H, Katanoda K, Matsuda T, Maeda Y, Matsuo K. Trends in non-Hodgkin lymphoma mortality rate in Japan and the United States: A population-based study. Cancer Sci. 2023;114(10):4073-4080.[PubMed]
      12. Tanaka H, Togawa K, Katanoda K. Impact of the COVID-19 pandemic on mortality trends in Japan: a reversal in 2021? A descriptive analysis of national mortality data, 1995-2021. BMJ Open. 2023;13(8):e071785. Published 2023 Aug 31.[PubMed]
      13. Saito E, Tanaka S, Abe SK, Hirayabashi M, Ishihara J, Katanoda K, Lin Y, Nagata C, Sawada N, Takachi R, Goto A, Tanaka J, Ueda K, Hori M, Matsuda T, Inoue M. Economic burden of cancer attributable to modifiable risk factors in Japan. Glob Health Med. 2023 Aug 31;5(4):238-245.[PubMed]
      14. Palmer M, Katanoda K, Saito E, Acuti Martellucci C, Tanaka S, Ikeda S, Sakamoto H, Machalek D, Brotherton JML, Hocking JS. Corrigendum to "Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis" [Vaccine 40(41) (2022) 5971-5996]. Vaccine. 2023 Sep 1:S0264-410X(23)00787-9.[PubMed]
      15. Funada S, Yoshioka T, Luo Y, Iwama T, Mori C, Yamada N, Yoshida H, Katanoda K, Furukawa TA. Global Trends in Highly Cited Studies in COVID-19 Research. JAMA Netw Open. 2023 Sep 5;6(9):e2332802.[PubMed]
      16. Nguyen PT, Hori M, Matsuda T, Katanoda K. Cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020-2050: A Statistical Modeling Study. Cancer Epidemiol Biomarkers Prev. 2023 Dec 1;32(12):1756-1770.[PubMed]
      17. Ong SK, Abe SK, Thilagaratnam S, Togawa K et al. Towards elimination of cervical cancer - human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries. Lancet Reg Health West Pac. 2023 Aug 1;39:100860.[PubMed]
      18. Kim J, Leon ME, Schinasi LH, Togawa K et al. Exposure to pesticides and risk of Hodgkin lymphoma in an international consortium of agricultural cohorts (AGRICOH). Cancer Causes Control. 2023;34(11):995-1003.[PubMed]
      19. Tsuge H, Kawakita D, Taniyama Y, Oze I, Koyanagi YN, Hori M, Nakata K, Sugiyama H, Miyashiro I, Oki I, Nishino Y, Katanoda K, Ito Y, Shibata A, Matsuda T, Iwasaki S, Matsuo K, Ito H. Subsite-specific trends in mid- and long-term survival for head and neck cancer patients in Japan: A population-based study. Cancer Sci. 2023 Nov 23.[PubMed]
      20. Boucheron P, Zietsman A, Pontac J, Hansen R, Anderson BO, Togawa K, Macharia PM, Foerster M, Schüz J, Dos-Santos-Silva I, McCormack V. Analysis of the Breast Cancer Journey in Namibia. JAMA Netw Open. 2023 Nov 1;6(11):e2341402.[PubMed]

和文

      1. 田中宏和, 田淵貴大, 片野田耕太. 新型コロナウイルスワクチン接種状況と接種証明書の活用に関する意識:2021年9-10月の調査(JACSIS研究). 日本公衆衛生雑誌. 2023;70(3):171-184, 2023
      2. 片野田 耕太, 伊藤 秀美, 伊藤 ゆり, 片山 佳代子, 西野 善一, 筒井 杏奈, 十川 佳代, 田中 宏和, 大野 ゆう子, 中谷 友樹.諸外国でのがん登録データの地理情報の利用事例とわが国の全国がん登録の諸問題:日本公衆衛生雑誌 70(3):163-170, 2023
      3. 柘植 博之, 川北 大介, 谷山 ゆかり, 小柳 友理子, 尾瀬 功, 片野田 耕太, 伊藤 ゆり, 松田 智大, 岩崎 真一, 伊藤 秀美.地域がん登録データより求めた,頭頸部がん長期生存率の経年変化 :頭頸部癌 49(2) 171-171,2023
      4. 片野田 耕太十川 佳代, 中村 正和.「たばこハームリダクション」は可能か?:国際的動向と日本での論点:日本公衆衛生雑誌,2023.(早期公開)
      5. 田中 宏和, 片野田 耕太. 【胆道癌と膵癌のリスクファクター】喫煙と発がん:胆と膵 44(9) 807-813, 2023

2022年

 英文

      1. Ito Y, Katanoda K, Yamamoto S, Hamajima N, Mochizuki Y, Matsuo K. Trends in smoking prevalence and attitude toward tobacco control among members of the JCA in 2004-2017. Cancer Sci. 2022 Apr;113(4):1542-1547. [PubMed]
      2. Kanehara R, Goto A, Watanabe T, Inoue K, Taguri M, Kobayashi S, Imai K, Saito E, Katanoda K, Iwasaki M et al. Association between diabetes and adjuvant chemotherapy implementation in patients with stage III colorectal cancer. J Diabetes Investig. 2022;13(10):1771-1778.[PubMed]
      3. Nguyen PT, Katanoda K, Saito E, Hori M, Nakayama T, Matsuda T. Trends in lung cancer incidence by gender, histological type and stage at diagnosis in Japan, 1993 to 2015: A multiple imputation approach. Int J Cancer. 2022 Jul 1;151(1):20-32. [PubMed]
      4. Pilleron S, Alqurini N, Ferlay J, Haase KR, Hannan M, Janssen-Heijnen M, Kantilal K, Katanoda K, Kenis C, Lu-Yao G et al. International trends in cancer incidence in middle-aged and older adults in 44 countries. J Geriatr Oncol. 2022 Apr;13(3):346-355. [PubMed]
      5. Tanaka S, Palmer M, Katanoda K. Trends in cervical cancer incidence and mortality of young and middle adults in Japan. Cancer Sci. 2022 May;113(5):1801-1807. [PubMed]
      6. Tanaka H, Nusselder WJ, Kobayashi Y, Mackenbach JP. Socioeconomic inequalities in self-rated health in Japan, 32 European countries and the United States: an international comparative study [published online ahead of print, 2022 May 10]. Scand J Public Health. 2022;14034948221092285.[PubMed]
      7. Dhungel B, Wada K, Tanaka H, Gilmour S. Time to update the Japanese standard population for comparing mortality rates  Arch Public Health. 2022 Jun 6;80(1):153. [PubMed]
      8. Y. K. Lau, S. Okawa, R. Meza, K. Katanoda and T. Tabuchi.: Nicotine dependence of cigarette and heated tobacco users in Japan, 2019: a cross-sectional analysis of the JASTIS Study. Tob Control. 2022 Aug;31(e1):e50-e56  [PubMed]
      9. M. Inoue-Choi, N. D. Freedman, E. Saito, S. Tanaka, M. Hirabayashi, N. Sawada, S. Tsugane, Y. Usui, H. Ito, C. Wang, A. Tamakoshi, T. Takeuchi, Y. Kitamura, M. Utada, K. Ozasa, Y. Sugawara, I. Tsuji, K. Wada, C. Nagata, T. Shimazu, T. Mizoue, K. Matsuo, M. Naito, K. Tanaka, K. Katanoda, M. Inoue, Development Research Group for the and Japan Evaluation of Cancer Prevention Strategies in Japan. Low-intensity cigarette smoking and mortality risks: a pooled analysis of prospective cohort studies in Japan. Int J Epidemiol. 2022 Aug 10;51(4):1276-1290.  [PubMed]
      10. Inoue-Choi M, Freedman ND, Saito E, Tanaka S, Hirabayashi M, Sawada N, Tsugane S, Usui Y, Ito H, Wang C, Tamakoshi A, Takeuchi T, Kitamura Y, Utada M, Ozasa K, Sugawara Y, Tsuji I, Wada K, Nagata C, Shimazu T, Mizoue T, Matsuo K, Naito M, Tanaka K, Katanoda K, Inoue M. Correction to: Low-intensity cigarette smoking and mortality risks: a pooled analysis of prospective cohort studies in Japan. Int J Epidemiol. 2022 Aug 10;51(4):1355.[PubMed]
      11. M. Ichikawa, H. Inada, K. Katanoda and S. Nakahara. Trend in alcohol-related crashes before and after the introduction of mandatory breath testing among commercial truck drivers [published online ahead of print, 2022 Aug 13]. J Epidemiol. 2022;10.2188/jea.JE20220054.[PubMed]
      12. Smith J, Togawa K, Dresler C, Hawari F, Zain ZM, Stewart B, Warren GW, Sitas F. Smoking cessation after a cancer diagnosis: Commentary on special supplement in Cancer Epidemiology. Cancer Epidemiol. 2022;79:102210. [PubMed]
      13. Palmer M, Katanoda K, Saito E, Acuti Martellucci C, Tanaka S, Ikeda S, Sakamoto H, Machelek D, Ml Brotherton J, Hocking JS. Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis. Vaccine. 2022 Sep 29;40(41):5971-5996. [PubMed]
      14. Yang SL, Togawa K, Gilmour S, Leon ME, Soerjomataram I, Katanoda K. Projecting the impact of implementation of WHO MPOWER measures on smoking prevalence and mortality in Japan[published online ahead of print, 2022 Sep 13]. Tob Control. [PubMed]
      15. Nguyen PT, Saito E, Katanoda K. Long-Term Projections of Cancer Incidence and Mortality in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020-2054: An Empirical Validation Approach. Cancers (Basel). 2022;14(24):6076. Published 2022 Dec 9. [PubMed]
      16. Katagiri R, Tabuchi T, Katanoda K. Socioeconomic and sociodemographic factors associated with food expense insufficiency during the COVID-19 pandemic in Japan. PLoS One. 2022;17(12):e0279266. Published 2022 Dec 15.[PubMed]
      17. Ozasa K, Katanoda K. A Special Issue on Fukushima Has Been Released a Decade After the Great East Japan Earthquake. J Epidemiol. 2022;32(Suppl_XII):S1-S2.[PubMed]
      18. Yoshida S, Okubo R, Katanoda K, Tabuchi T. Impact of state of emergency for coronavirus disease 2019 on hospital visits and disease exacerbation: the Japan COVID-19 and Society Internet Survey. Fam Pract. 2022;39(5):883-890.[PubMed]
      19. Kurokawa T, Ozaki A, Bhandari D, Kotera Y, Sawano T, Kanemoto Y, Kanzaki N, Ejiri T, Saito H, Kaneda Y, Tsubokura M, Tanimoto T, Katanoda K, Tabuchi T. Association between COVID-19 incidence and postponement or cancellation of elective surgeries in Japan until September 2020: a cross-sectional, web-based survey. BMJ Open. 2022 Oct 10;12(10):e059886. [PubMed]
      20. Inoue M, Hirabayashi M, Abe SK, Katanoda K, Sawada N, Lin Y, Ishihara J, Takachi R, Nagata C, Saito E, Goto A, Ueda K, Tanaka J, Hori M, Matsuda T; Cancer PAF Japan Collaborators. Burden of cancer attributable to modifiable factors in Japan in 2015. Glob Health Med. 2022 Feb 28;4(1):26-36. [PubMed]
      21. Takenobu K, Yoshida S, Katanoda K, Kawakami K, Tabuchi T. Impact of workplace smoke-free policy on secondhand smoke exposure from cigarettes and exposure to secondhand heated tobacco product aerosol during COVID-19 pandemic in Japan: the JACSIS 2020 study. BMJ Open. 2022;12(3):e056891. Published 2022 Mar 18.[PubMed]
      22. Kitajima T, Schüz J, Morita A, Ikeda W, Tanaka H, Togawa K, Gabazza EC, Taki M, Toriyabe K, Ikeda T, Sokejima S. Measurement of intermediate frequency magnetic fields generated by household induction cookers for epidemiological studies and development of an exposure estimation model. Int J Environ Res Public Health. 2022;19(19): 11912.[PubMed]
      23. Kuurdor ED, Tanaka H, Kitajima T, Amexo JX, Sokejima S. Social capital and self-rated health: a cross-sectional study among rural Japanese working residents. Int J Environ Res Public Health. 2022;19(21): 14018.[PubMed]

和文

      1. 片野田耕太 . 新 高等保健体育 指導ノート 保健編 1現代社会と健康. 13 喫煙と健康.東京, 大修館書店: 216-229,2022
      2. 伊藤 ゆり, 堀 芽久美, 福井 敬祐, 太田 将仁, 中田 佳世, 杉山 裕美, 伊藤 秀美, 大木 いずみ, 西野 善一, 宮代 勲, 片野田 耕太, 柴田 亜希子, 松田 智大.20年間でがん患者の生存率は向上したか?6府県の住民ベースのがん登録による検討. Journal of Epidemiology 32(Suppl.1) 90-90, 2022
      3. 片野田 耕太.【UP DATE 新型タバコ-COVID-19も絡むタバコ問題の今】UP DATE 最新タバコ研究. 公衆衛生 86(2) 169-176 ,2022
      4. 奥山絢子, 片野田耕太, 田淵貴大., 基礎疾患保持者の新型コロナウイルス感染症に対する認識と受療状況:2020年8月~9月の状況についてのアンケート調査:日本公衆衛生学雑誌, 69(3) 204-214, 2022
      5. 北原 慈和, 長井 万恵, 井手野 由季, 片野田 耕太, 岩瀬 明, 林 邦彦. 日本ナースヘルス研究(JNHS)からみた更年期について. 糖尿病・内分泌代謝科編集委員会 編 54(3) 351-357, 2022
      6. 福井敬祐, 伊藤ゆり, 片野田 耕太. 都道府県別にみるがん年齢調整死亡率の推移予測ツールの開発. 厚生の指標 69(5) 1-6, 2022
      7. 片野田 耕太.【日常生活に潜む健康被害】家庭内の喫煙による家族への影響. 保健の科学 64(10) 657-663, 2022

2021年

 英文

      1. Katanoda K, Hori M, Saito E, Shibata A, Ito Y, Minami T, Ikeda S, Suzuki T, Matsuda T. Updated trends in cancer in Japan: incidence in 1985-2015 and mortality in 1958-2018 - a sign of decrease in cancer incidence. J Epidemiol, 2021 Jul 5;31(7):426-450. [PubMed]
      2. Hori M, Tanaka H, Saito E, Wakai K, Katanoda K. Response to the Dr Shikata's letter: 'Secondhand smoke exposure and risk of lung cancer in Japan: a systematic review and meta-analysis of epidemiologic studies'. Jpn J Clin Oncol, 2021 Apr 1;51(4):661. [PubMed]
      3. Lau YK, Okawa S, Meza R, Katanoda K, Tabuchi T. Nicotine dependence of cigarette and heated tobacco users in Japan, 2019: a cross-sectional analysis of the JASTIS Study. Tob Control.2022;31(e1):e50-e56. [PubMed]
      4. Mawditt C, Sasayama K, Katanoda K, Gilmour S. The clustering of health-related behaviours in the adult Japanese population. J Epidemiol, 2021 Aug 5;31(8):471-479. [PubMed]
      5. Shirabe R, Saito E, Sawada N, Ishihara J, Takachi R, Abe SK, Shimazu T, Yamaji T, Goto A, Iwasaki M, Inoue M, Tsugane S. Fermented and nonfermented soy foods and the risk of breast cancer in a Japanese population-based cohort study. Cancer Med, 2021 Jan;10(2):757-771. [PubMed]
      6. Zha L, Liu R, Sobue T, Kitamura T, Ishihara J, Kotemori A, Ikeda S, Sawada N, Iwasaki M, Tsugane S, For The Jphc Study Group. Dietary Acrylamide Intake and the Risk of Hematological Malignancies: The Japan Public Health Center-Based Prospective Study. Nutrients, 2021 Feb 11;13(2):590. [PubMed]
      7. Saito E, Inoue M, Sawada N, Kokubo Y, Yamagishi K, Iso H, Shimazu T, Yamaji T, Iwasaki M, Tsugane S. Risk of stroke in cancer survivors using a propensity score-matched cohort analysis. Sci Rep, 2021 Mar 10;11(1):5599. [PubMed]
      8. Yang JJ, Yu D, Shu XO, Freedman ND, Wen W, Rahman S, Abe SK, Saito E, Gupta PC, He J, Tsugane S, Gao YT, Xiang YB, Yuan JM, Tomata Y, Tsuji I, Sugawara Y, Matsuo K, Ahn YO, Park SK, Chen Y, Pan WH, Pednekar M, Gu D, Sawada N, Cai H, Li HL, Koh WP, Wang R, Zhang S, Kanemura S, Ito H, Shin MH, Wu PE, Yoo KY, Ahsan H, Chia KS, Boffetta P, Inoue M, Kang D, Potter JD, Zheng W. Quantifying the association of low-intensity and late initiation of tobacco smoking with total and cause-specific mortality in Asia. Tob Control, 2021 May;30(3):328-335. [PubMed]
      9. Acuti Martellucci C, Nomura S, Yoneoka D, Ueda P, Brotherton J, Canfell K, Palmer M, Manzoli L, Giorgi Rossi P, De Togni A, Palmonari C, Califano A, Saito E, Hashizume M, Shibuya K. Human papillomavirus vaccine effectiveness within a cervical cancer screening programme: cohort study. BJOG, 2021 Feb;128(3):532-539. [PubMed]
      10. Saito E, Niino M. Age-specific incidence rates of gallbladder cancer in the world. Jpn J Clin Oncol, 2021 Feb 8;51(2):312-313. [PubMed]
      11. Hori M, Palmer M. Age-specific prostate cancer incidence rate in the world. Jpn J Clin Oncol, 51:164-165, 2021 Jal 1;51(1):164-165. [PubMed]
      12. Ikeda S, Sobue T, Kitamura T, Ishihara J, Kotemori A, Zha L, Liu R, Sawada N, Iwasaki M, Tsugane S, On Behalf Of The Jphc Study Group. Dietary Acrylamide Intake and the Risks of Renal Cell, Prostate, and Bladder Cancers: A Japan Public Health Center-Based Prospective Study. Nutrients, 2021 Feb 27;13(3):780. [PubMed]
      13. Ikeda S, Ueda Y, Hara M, Yagi A, Kitamura T, Kitamura Y, Konishi H, Kakizoe T, Sekine M, Enomoto T, Sobue T. Human papillomavirus vaccine to prevent cervical intraepithelial neoplasia in Japan: A nationwide case-control study. Cancer Sci, 112:839-846, 2021 Feb;112(2):839-846. [PubMed]
      14. Abe SK, Narita S, Saito E, Sawada N, Shimazu T, Goto A, Yamaji T, Iwasaki M, Inoue M, Tsugane S. Body mass  index,  height,  weight  change,  and  subsequent  lung  cancer  risk:  the  Japan  Public  Health Center- based   Prospective   Study.   Cancer   Epidemiol   Biomarkers   Prev.   2021  Sep;30(9):1708-1716.[PubMed]
      15. Mizuno T, Yoshida T, Sunami K, Koyama T, Okita N, Kubo T, Sudo K, Shimoi T, Ueno H, Saito E, Katanoda K, Shibata T, Yonemori K, Okusaka T, Boku N, Ohe Y, Hiroshima Y, Ueno M, Kuboki Y, Doi T, Nakamura K, Kohno T, Yatabe Y, Yamamoto N., Study protocol for NCCH1908 (UPFRONT-trial): a prospective clinical trial to evaluate the feasibility and utility of comprehensive genomic profiling prior to the initial systemic treatment in advanced solid tumour patients, Jpn J Clin Oncol. 2021 Dec 1;51(12):1757-1760. [PubMed]
      16. Sasaki Y, Abe Y, Shoji M, Mizumoto N, Takeda H, Oizumi H, Yaoita T, Sawada N, Yamagishi K, Saito E, Watanabe M, Ishizawa K, Konta T, Kayama T, Tsugane S, Ueno Y, Inoue M. Reliability of self-reported questionnaire for epidemiological investigation of Helicobacter pylori eradication in a population-based cohort study. Sci Rep. 2021 Aug 2;11(1):15605. [PubMed]
      17. Shin S, Lee JE, Loftfield E, Shu XO, Abe SK, Rahman MS, Saito E, Islam MR, Tsugane S, Sawada N, Tsuji I, Kanemura S, Sugawara Y, Tomata Y, Sadakane A, Ozasa K, Oze I, Ito H, Shin MH, Ahn YO, Park SK, Shin A, Xiang YB, Cai H, Koh WP, Yuan JM, Yoo KY, Chia KS, Boffetta P, Ahsan H, Zheng W, Inoue M, Kang D, Potter JD, Matsuo K, Qiao YL, Rothman N, Sinha R. Coffee and tea consumption and mortality from all causes, cardiovascular disease and cancer: a pooled analysis of prospective studies from the Asia Cohort Consortium. Int J Epidemiol. 2022 May 9;51(2):626-640. [PubMed]
      18. Svensson T, Saito E, Svensson AK, Melander O, Orho-Melander M, Mimura M, Rahman S, Sawada N, Koh WP, Shu XO, Tsuji I, Kanemura S, Park SK, Nagata C, Tsugane S, Cai H, Yuan JM, Matsuyama S, Sugawara Y, Wada K, Yoo KY, Chia KS, Boffetta P, Ahsan H, Zheng W, Kang D, Potter JD, Inoue M. Association of Sleep Duration With All- and Major-Cause Mortality Among Adults in Japan, China, Singapore, and Korea. JAMA Netw Open. 2021 Sep 1;4(9):e2122837. [PubMed]
      19. Yang JJ, Yu D, Shu XO, Wen W, Rahman S, Abe S, Saito E, Gupta PC, He J, Tsugane S, Gao YT, Yuan JM, Koh WP, Sadakane A, Tomata Y, Tsuji I, Sugawara Y, Matsuo K, Ahn YO, Park SK, Chen Y, Inoue M, Kang D, Zheng W. Reduction in total and major cause-specific mortality from tobacco smoking cessation: a pooled analysis of 16 population-based cohort studies in Asia. Int J Epidemiol. 2021 Feb 5;dyab087. [PubMed]
      20. Inoue-Choi M, Freedman N, Saito E, Tanaka S, Hirabayashi M, Sawada N, Tsugane S, Usui Y, Ito H, Wang C, Tamakoshi A, Takeuchi T, Kitamura Y, Utada M, Ozasa K, Sugawara Y, Tsuji I, Wada K, Nagata C, Shimazu T, Mizoue T, Matsuo K, Naito M, Tanaka K, Katanoda K, Inoue M. Low-intensity cigarette smoking and mortality risks: a pooled analysis of prospective cohort studies in Japan [published correction appears in Int J Epidemiol. 2022 Feb 25;:]. Int J Epidemiol. 2022;51(4):1276-1290. [PubMed]
      21. Charvat H, Saito E. Age-specific larynx cancer incidence rate in the world. Jpn J Clin Oncol. 2021 2021 Jul 1;51(7):1181-1182. [PubMed]
      22. Palmer M, Katanoda K, Saito E, Martellucci CA, Ostuki S, Nomura S, Ota E, Brotherton JML, Hocking J. National genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: a systematic review and meta-analysis protocol. Syst Rev. 2021 May 5;10(1):135. [PubMed]
      23. Toyoda, Y., Katanoda, K., Ishii, K., Yamamoto, H., Tabuchi, T. Negative impact of the COVID-19 state of emergency on breast cancer screening participation in Japan., Breast Cancer, 2021 Nov;28(6):1340-1345. [PubMed]
      24. Ohmomo, H., Harada, S., Komaki, S., Ono, K., Sutoh, Y., Otomo, R., Umekage, S., Hachiya, T., Katanoda, K., Takebayashi, T., Shimizu, A., DNA methylation abnormalities and altered whole transcriptome profiles after switching from combustible tobacco smoking to heated tobacco products. Cancer Epidemiol Biomarkers Prev. 2022 Jan;31(1):269-279. [PubMed]
      25. Nakata, K., Hiyama, E., Katanoda, K., Matsuda, T., Tada, Y., Inoue, M., Kawa, K., Maru, M., Shimizu, C., Horibe, K., Miyashiro, I., Cancer in Adolescents and Young Adults in Japan - Epidemiology and Cancer strategy. Int J Clin Oncol. 2022 Jan;27(1):7-15. [PubMed]
      26. Katanoda, K., Ito, Y., Sobue., T. International comparison of trends in cancer mortality: Japan has fallen behind in screening-related cancers., Jpn J Clin Oncol, 2021 Nov 1;51(11):1680-1686.  [PubMed]
      27. Katanoda, K., Ideno, Y., Maruoka, N., Nagai, K., Tsukada, Y., Matsuki, M., Higashi, T., Hayashi, K.,, Validation of identifying cancer diagnosis based on self-reported information in the Japan Nurses’ Health Study. Asian Pac J Cancer Prev. 2022 Feb 1;23(2):651-657. [PubMed]
      28. Fong, G.T., Yuan, J., Craig, L.V., Xu, S.S., Meng, G., Quah, A.C.K., Seo, H.G., Lee, S., Yoshimi, I., Katanoda, K., Tabuchi, T., Achieving the Goals of Healthy China 2030 Depends on Increasing Smoking Cessation in China: Comparative Findings from the ITC Project in China, Japan, and the Republic of Korea. China CDC Wkly. 2021 May 28;3(22):463-467.  [PubMed]
      29. Togawa K, Leon ME, Lebailly P, Beane Freeman LE, Nordby KC, Baldi I, MacFarlane E, Shin A, Park S, Greenlee RT, Sigsgaard T, Basinas I, Hofmann JN, Kjaerheim K, Douwes J, Denholm R, Ferro G, Sim MR, Kromhout H, Schüz J. Cancer incidence in agricultural workers: Findings from an international consortium of agricultural cohort studies (AGRICOH). Environ Int. 2021 Dec;157:106825.  [PubMed]
      30. Togawa K, Ma H, Smith AW, Neuhouser ML, George SM, Baumgartner KB, McTiernan A, Baumgartner R, Ballard RM, Bernstein L. Self-reported symptoms of arm lymphedema and health-related quality of life among female breast cancer survivors. Sci Rep. 2021 May 21;11(1):10701.  [PubMed]
      31. Onyije FM, Hosseini B, Togawa K, Schüz J, Olsson A. Cancer Incidence and Mortality among Petroleum Industry Workers and Residents Living in Oil Producing Communities: A Systematic Review and Meta- Analysis. Int J Environ Res Public Health. 2021 Apr 20;18(8):4343. [PubMed]
      32. Le PM, Nguyen TP, Nguyen HV, Bui DH, Vo SH, Nguyen NV, Nguyen TV, Tran AT, Le AD, Ha NM, Dao AT, Gilmour S. Adherence to highly active antiretroviral therapy among people living with HIV and associated high-risk behaviours and clinical characteristics: A cross-sectional survey in Vietnam. Int J STD AIDS., 2021 Sep;32(10):911-918.  [PubMed]
      33. Nguyen TP, Rahman MS, Le PM, Nguyen HV, Vu KD, Nguyen HL, Dao ATM, Khuong LQ, Hoang MV, Gilmour S. Trends in, projections of, and inequalities in reproductive, maternal, newborn and child health service coverage in Vietnam 2000-2030: A Bayesian analysis at national and sub-national levels. Lancet Reg Health West Pac. 2021;15時10分0230. Published 2021 Jul 30.[PubMed]
      34. Nguyen TP, Wong ZS, Wang L, Thanh TT, Van Nguyen H, Gilmour S. Rapid impact assessments of COVID-19 control measures against the Delta variant and short-term projections of new confirmed cases in Vietnam. J Glob Health. 2021;11時3分118. Published 2021 Nov 4. [PubMed]
      35. Kamo, K., et al. "How much can screening reduce colorectal cancer mortality in Japan? Scenario-based estimation by microsimulation." Jpn J Clin Oncol. 2022 Mar 3;52(3):221-226. [PubMed]
      36. Saito, E., Yano, T., Hori, M., Yoneoka, D., Matsuda, T., Chen, Y., Katanoda, K., Is young-onset esophageal adenocarcinoma increasing in Japan? An analysis of population-based cancer registries. Cancer Med. 2022 Mar;11(5):1347-1356. [PubMed]
      37. Corbin S, Togawa K, Schüz J, Le Cornet C, Fervers B, Feychting M, Wiebert P, Hansen J, Dalton SO, Kjæ rheim K, Nordby KC, Østrem RS, Skakkebæk NE, Uuksulainen S, Pukkala E, Olsson A. Parental occupational exposures in wood-related jobs and risk of testicular germ cell tumours in offspring in NORD-TEST a registry-based case-control study in Finland, Norway, and Sweden. Int Arch Occup Environ Health. 2022;95(6):1243-1253. [PubMed]
      38. Martellucci CA et al. (2021) Delivering cervical cancer screening during the COVID-19 emergency. BMJ Sexual and Reproductive Health. 2021 Oct;47(4):296-299. [PubMed]
      39. Martellucci CA et. al (2021) Wide variability in colorectal cancer screening uptake by general practitioner: Cross sectional study. J Med Screen. 2022 Mar;29(1):21-25. [PubMed]
      40. Katanoda, K. (2022). "Message From the New Editor-in-Chief." J Epidemiol 2022;32(1):1. [PubMed]
      41. Phuong, N. T., et al. (2022). "Trends in lung cancer incidence by gender, histological type and stage at diagnosis in Japan, 1993–2015: A multiple imputation approach." Int J Cancer. 2022 Jul 1;151(1):20-32. [PubMed]
      42. Takeuchi, E., et al. (2022). "Restrictions on healthcare utilization and psychological distress among patients with diseases potentially vulnerable to COVID-19; the JACSIS 2020 study." Health Psychol Behav Med. 2022 Feb 9;10(1):229-240. [PubMed]

和文

      1. 片野田 耕太, 野田 光彦, 後藤 温, 水沼 英樹, 李 廷秀, 林 邦彦. 女性における思春期の低体重と成人発症糖尿病との関連 日本ナースヘルス研究. 日本女性医学学会雑誌, 28:236-241, 2021
      2. 堀 芽久美, 齋藤 英子, 片山 梨奈, 片野田 耕太. 全国市区町村別がん死亡・罹患地図表示ツール(Cancer Map)開発の紹介. JACR Monograph (26) 22-22 ,2021
      3. 齋藤 英子, 堀 芽久美, 松田 智大, 米岡 大輔, 伊藤 ゆり, 片野田 耕太. 前立腺がん罹患率の臨床進行度別年次推移 多重代入法を用いた検討. JACR Monograph (26) 16-16 ,2021
      4. 片野田 耕太, 堀 芽久美, 齋藤 英子. がんの年齢調整死亡率の都道府県順位変化の検討. JACR Monograph (26) 15-15, 2021
      5. 堀 芽久美, 片山 梨奈, 齊藤 英子, 片野田 耕太. 全国市区町村別がん死亡・罹患地図表示ツール(Cancer Map)開発の紹介. JACR Monograph (26) 83-83, 2021
      6. 齋藤 英子, 堀 芽久美, 松田 智大, 米岡 大輔, 伊藤 ゆり, 片野田 耕太.  前立腺がん罹患率の臨床進行度別年次推移 多重代入法を用いた検討. JACR Monograph (26) 44-44, 2021
      7. 片野田 耕太, 堀 芽久美, 齋藤 英子. がんの年齢調整死亡率の都道府県順位変化の検討. JACR Monograph (26) 43-43 ,2021
      8. 齋藤 英子, Shah Richa, 片野田 耕太. 【希少がん-がん診療の新たな課題-】希少がん総論 希少がんと医療経済. 日本臨床 79(増刊1 希少がん) 153-157 ,2021

2020年

 英文

      1. Hori M, Saito E, Katanoda K, Tsugane S. Estimation of lifetime cumulative mortality risk of lung cancer by smoking status in Japan. Jpn J Clin Oncol, 2020 Sep 28;50(10):1218-1224. [PubMed]
      2. Saito E, Hori M, Matsuda T, Yoneoka D, Ito Y, Katanoda K. Long-term Trends in Prostate Cancer Incidence by Stage at Diagnosis in Japan Using the Multiple Imputation Approach, 1993-2014. Cancer Epidemiol Biomarkers Prev, 2020 Jun;29(6):1222-1228. [PubMed]
      3. Huang HL, Leung CY, Saito E, Katanoda K, Hur C, Kong CY, Nomura S, Shibuya K. Effect and cost-effectiveness of national gastric cancer screening in Japan: a microsimulation modeling study. BMC Med, 2020 Sep 14;18(1):257. [PubMed]
      4. Leung CY, Huang HL, Rahman MM, Nomura S, Krull Abe S, Saito E, Shibuya K. Cancer incidence attributable to tuberculosis in 2015: global, regional, and national estimates. BMC Cancer, 2020 May 12;20(1):412. [PubMed]
      5. Saito E, Goto A, Kanehara R, Ohashi K, Noda M, Matsuda T, Katanoda K. Prevalence of diabetes in Japanese patients with cancer. J Diabetes Investig, 2020 Sep;11(5):1159-1162. [PubMed]
      6. Usui Y, Ito H, Koyanagi Y, Shibata A, Matsuda T, Katanoda K, Maeda Y, Matsuo K. Changing trend in mortality rate of multiple myeloma after introduction of novel agents: A population-based study. Int J Cancer, 2020 Dec 1;147(11):3102-3109. [PubMed]
      7. Saito E, Tang X, Abe SK, Sawada N, Ishihara J, Takachi R, Iso H, Shimazu T, Yamaji T, Iwasaki M, Inoue M, Tsugane S. Association between meat intake and mortality due to all-cause and major causes of death in a Japanese population. PLoS One, 2020 Dec 15;15(12):e0244007. [PubMed]
      8. Zhu J, Smith-Warner SA, Yu D, Zhang X, Blot WJ, Xiang YB, Sinha R, Park Y, Tsugane S, White E, Koh WP, Park SK, Sawada N, Kanemura S, Sugawara Y, Tsuji I, Robien K, Tomata Y, Yoo KY, Kim J, Yuan JM, Gao YT, Rothman N, Lazovich D, Abe SK, Rahman MS, Loftfield E, Takata Y, Li X, Lee JE, Saito E, Freedman ND, Inoue M, Lan Q, Willett WC, Zheng W, Shu XO. Associations of coffee and tea consumption with lung cancer risk [published online ahead of print, 2020 Dec 16]. Int J Cancer. 2020;10.1002/ijc.33445.[PubMed]
      9. Hirabayashi M, Inoue M, Sawada N, Saito E, Abe SK, Hidaka A, Iwasaki M, Yamaji T, Shimazu T, Tsugane S. Author Correction: Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study. Sci Rep, 2020 Jul 28;10(1):12950. [PubMed]
      10. Palmer M, Saito E. Age-specific incidence rates of ovarian cancer worldwide. Jpn J Clin Oncol, 2020 Sep 5;50(9):1086-1087. [PubMed]
      11. Hori M, Palmer M. International comparison of multiple myeloma incidence. Jpn J Clin Oncol, 2020 Feb 17;50(2):221-222 [PubMed]
      12. Saito E, Hori M. Age-specific cervical cancer incidence rate in the world. Jpn J Clin Oncol, 2020 Sep 28;50(10):1229-1230. [PubMed]
      13. Saito E, Hori M. Corrigendum to: Age specific colorectal cancer incidence rate in the world. Jpn J Clin Oncol, 2020 Dec 16;50(12):1483. [PubMed]
      14. Hori M, Okuyama A. Age-specific incidence rates of stomach cancer in the world. Jpn J Clin Oncol, 2020 Jun 10;50(6):724-725. [PubMed]
      15. Ono A, Inoue M, Sawada N, Saito E, Yamaji T, Shimazu T, Goto A, Iwasaki M, Tsugane S. Impact of alcohol drinking on cancer risk with consideration of flushing response: The Japan Public Health Center-based Prospective Study Cohort (JPHC study) [published online ahead of print, 2020 Feb 11]. Prev Med. 2020;133:106026.[PubMed]
      16. Svensson T, Inoue M, Saito E, Sawada N, Iso H, Mizoue T, Goto A, Yamaji T, Shimazu T, Iwasaki M, Tsugane S. The association between habitual sleep duration and mortality according to sex and age: the Japan Public Health Center-based Prospective Study. J Epidemiol, 2021 Feb 5;31(2):109-118. [PubMed]
      17. Saito E, Matsuoka J. International comparison of Hodgkin and non-Hodgkin lymphoma incidence. Jpn J Clin Oncol, 2020 Jan 24;50(1):96-97. [PubMed]
      18. Zha L, Sobue T, Kitamura T, Kitamura Y, Ishihara J, Kotemori A, Liu R, Ikeda S, Sawada N, Iwasaki M, Tsugane S, Jphc Study Group FT. Dietary Acrylamide Intake and the Risk of Liver Cancer: The Japan Public Health Center-Based Prospective Study. Nutrients, 2020 Aug 19;12(9):2503. [PubMed]
      19. Liu R, Zha L, Sobue T, Kitamura T, Ishihara J, Kotemori A, Ikeda S, Sawada N, Iwasaki M, Tsugane S. Dietary Acrylamide Intake and Risk of Lung Cancer: The Japan Public Health Center Based Prospective Study. Nutrients, 2020 Aug 12;12(8):2417. [PubMed]
      20. Nakagawa S, Ueda Y, Yagi A, Ikeda S, Hiramatsu K, Kimura T. Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan. Cancer Sci, 2020 Jun;111(6):2156-2162. [PubMed]
      21. Yagi A, Ueda Y, Nakagawa S, Ikeda S, Tanaka Y, Sekine M, Miyagi E, Enomoto T, Kimura T. Potential for cervical cancer incidence and death resulting from Japan's current policy of prolonged suspension of its governmental recommendation of the HPV vaccine. Sci Rep, 2020 ep 29;10(1):15945. [PubMed]
      22. Sekine M, Yamaguchi M, Kudo R, J B Hanley S, Hara M, Adachi S, Ueda Y, Miyagi E, Ikeda S, Yagi A, Enomoto T. Epidemiologic Profile of Type-Specific Human Papillomavirus Infection after Initiation of HPV Vaccination. Vaccines (Basel), 2020 Jul 29;8(3):425. [PubMed]
      23. Yagi A, Ueda Y, Masuda T, Ikeda S, Miyatake T, Nakagawa S, Hirai K, Nakayama T, Miyagi E, Enomoto T, Kimura T. Japanese Mothers' Intention to HPV Vaccinate Their Daughters: How Has It Changed over Time Because of the Prolonged Suspension of the Governmental Recommendation? Vaccines (Basel), 2020 Sep 3;8(3):502. [PubMed]

和文

      1. 片野田 耕太. 【改正健康増進法-変わる受動喫煙対策-】受動喫煙の健康影響とその歴史. 保健医療科学, 69:103-113, 2020
      2. 中村 正和, 田淵 貴大, 尾崎 米厚, 大和 浩, 欅田 尚樹, 吉見 逸郎, 片野田 耕太, 加治 正行, 揚松 龍治. 加熱式たばこ製品の使用実態、健康影響、たばこ規制への影響とそれを踏まえた政策提言. 日本公衆衛生雑誌, 67:3-14, 2020

2019年

  英文

      1. Katanoda K, Saito E. Laryngeal cancer incidence rates in the world from the Cancer Incidence in Five Continents XI. Jpn J Clin Oncol, 2019 Jan 1;49(1):100-101. [PubMed]
      2. Katanoda K, Noda M, Goto A, Mizunuma H, Lee JS, Hayashi K. Being underweight in adolescence is independently associated with adult-onset diabetes among women: The Japan Nurses' Health Study. J Diabetes Investig, 2019 May;10(3):827-836. [PubMed]
      3. Matsuoka J, Katanoda K. Incidence rates of malignant lymphoma in the world from the Cancer Incidence in Five Continents XI. Jpn J Clin Oncol, 2019 Apr 1;49(4):393-394. [PubMed]
      4. Katanoda K, Matsuoka J. Incidence rates of thyroid cancer in the world from the Cancer Incidence in Five Continents XI. Jpn J Clin Oncol, 2019 Jun 1;49(6):587-588. [PubMed]
      5. Yasuda S, Iuchi T, Goto A, Katanoda K, Iida S, Oikawa Y, Namba A, Isshiki M, Inoue I, Kamei Y, Shimada A, Noda M. Weight control before and during pregnancy for patients with gestational diabetes mellitus. J Diabetes Investig, 2019 Jul;10(4):1075-1082. [PubMed]
      6. Liu R, Kitamura Y, Kitamura T, Sobue T, Sado J, Sugawara Y, Matsuo K, Nakayama T, Tsuji I, Ito H, Suzuki T, Katanoda K, Tominaga S. Reproductive and lifestyle factors related to breast cancer among Japanese women: An observational cohort study. Medicine (Baltimore), 2019 Dec;98(51):e18315. [PubMed]
      7. Sado J, Kitamura T, Kitamura Y, Liu R, Ando E, Sobue T, Sugawara Y, Matsuo K, Nakayama T, Tsuji I, Ito H, Suzuki T, Katanoda K, Tominaga S. Coffee Consumption and All-Cause and Cardiovascular Mortality - Three-Prefecture Cohort in Japan. Circ J, 2019 Mar 25;83(4):757-766. [PubMed]
      8. Yako-Suketomo H, Katanoda K, Kawamura Y, Katayama K, Yuasa M, Horinouchi H, Saito K. Children's Knowledge of Cancer Prevention and Perceptions of Cancer Patients: Comparison Before and After Cancer Education with the Presence of Visiting Lecturer -Guided Class. J Cancer Educ, 2019 Dec;34(6):1059-1066.  [PubMed]
      9. Yang JJ, Yu D, Wen W, Saito E, Rahman S, Shu XO, Chen Y, Gupta PC, Gu D, Tsugane S, Xiang YB, Gao YT, Yuan JM, Tamakoshi A, Irie F, Sadakane A, Tomata Y, Kanemura S, Tsuji I, Matsuo K, Nagata C, Chen CJ, Koh WP, Shin MH, Park SK, Wu PE, Qiao YL, Pednekar MS, Sawada N, Li HL, Gao J, Cai H, Wang R, Sairenchi T, Grant E, Sugawara Y, Zhang S, Ito H, Wada K, Shen CY, Pan WH, Ahn YO, You SL, Fan JH, Yoo KY, Ashan H, Chia KS, Boffetta P, Inoue M, Kang D, Potter JD, Zheng W. Association of Diabetes With All-Cause and Cause-Specific Mortality in Asia: A Pooled Analysis of More Than 1 Million Participants. JAMA Netw Open, 2019 Apr 5;2(4):e192696. [PubMed]
      10. Yang K, Zhang Y, Saito E, Rahman MS, Gupta PC, Sawada N, Tamakoshi A, Gao YT, Koh WP, Shu XO, Tsuji I, Sadakane A, Nagata C, You SL, Yuan JM, Shin MH, Chen Y, Pan WH, Pednekar MS, Tsugane S, Cai H, Xiang YB, Ozasa K, Tomata Y, Kanemura S, Sugawara Y, Wada K, Wang R, Ahn YO, Yoo KY, Ahsan H, Chia KS, Boffetta P, Kang D, Potter JD, Inoue M, Zheng W, Nan H. Association between educational level and total and cause-specific mortality: a pooled analysis of over 694 000 individuals in the Asia Cohort Consortium. BMJ Open, 2019 Aug 22;9(8):e026225. [PubMed]
      11. Hirabayashi M, Inoue M, Sawada N, Saito E, Abe SK, Hidaka A, Iwasaki M, Yamaji T, Shimazu T, Tsugane S. Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study. Sci Rep, 2019 Apr 15;9(1):6099. [PubMed]
      12. Abe SK, Saito E, Sawada N, Tsugane S, Ito H, Lin Y, Tamakoshi A, Sado J, Kitamura Y, Sugawara Y, Tsuji I, Nagata C, Sadakane A, Shimazu T, Mizoue T, Matsuo K, Naito M, Tanaka K, Inoue M. Coffee consumption and mortality in Japanese men and women: A pooled analysis of eight population-based cohort studies in Japan (Japan Cohort Consortium). Prev Med. 2019;123時27分0-277. [PubMed]
      13. Abe SK, Saito E, Sawada N, Tsugane S, Ito H, Lin Y, Tamakoshi A, Sado J, Kitamura Y, Sugawara Y, Tsuji I, Nagata C, Sadakane A, Shimazu T, Mizoue T, Matsuo K, Naito M, Tanaka K, Inoue M. Green tea consumption and mortality in Japanese men and women: a pooled analysis of eight population-based cohort studies in Japan. Eur J Epidemiol, 2019 Oct;34(10):917-926. [PubMed]
      14. Ugai T, Ito H, Oze I, Saito E, Rahman MS, Boffetta P, Gupta PC, Sawada N, Tamakoshi A, Shu XO, Koh WP, Gao YT, Sadakane A, Tsuji I, Park SK, Nagata C, You SL, Pednekar MS, Tsugane S, Cai H, Yuan JM, Xiang YB, Ozasa K, Tomata Y, Kanemura S, Sugawara Y, Wada K, Chen CJ, Yoo KY, Chia KS, Ahsan H, Zheng W, Inoue M, Kang D, Potter J, Matsuo K. Association of BMI, Smoking, and Alcohol with Multiple Myeloma Mortality in Asians: A Pooled Analysis of More than 800,000 Participants in the Asia Cohort Consortium. Cancer Epidemiol Biomarkers Prev, 2019 Nov;28(11):1861-1867. [PubMed]
      15. Hirabayashi M, Inoue M, Sawada N, Saito E, Abe SK, Hidaka A, Iwasaki M, Yamaji T, Shimazu T, Shibuya K, Tsugane S. Effect of body-mass index on the risk of gastric cancer: A population-based cohort study in A Japanese population. Cancer Epidemiol, 2019 Dec;63:101622. [PubMed]
      16. Hosgood HD 3rd, Klugman M, Matsuo K, White AJ, Sadakane A, Shu XO, Lopez-Ridaura R, Shin A, Tsuji I, Malekzadeh R, Noisel N, Bhatti P, Yang G, Saito E, Rahman S, Hu W, Bassig B, Downward G, Vermeulen R, Xue X, Rohan T, Abe SK, Broët P, Grant EJ, Dummer TJB, Rothman N, Inoue M, Lajous M, Yoo KY, Ito H, Sandler DP, Ashan H, Zheng W, Boffetta P, Lan Q. The establishment of the Household Air Pollution Consortium (HAPCO). Atmosphere (Basel), 2019 Jul;10(7):10.3390/atmos10070422. [PubMed]
      17. Nakagawa-Senda H, Hori M, Matsuda T, Ito H. Prognostic impact of tumor location in colon cancer: the Monitoring of Cancer Incidence in Japan (MCIJ) project. BMC Cancer, 2019 May 9;19(1):431. [PubMed]
      18. Inoue S, Ito H, Hosono S, Hori M, Matsuda T, Mizuno M, Kato K, Matsuo K. Net Survival of Elderly Patients with Gynecological Cancer Aged Over 75 Years in 2006-2008. Asian Pac J Cancer Prev, 2019 Feb 26;20(2):437-442. [PubMed]
      19. Yang JJ, Yu D, Wen W, Shu XO, Saito E, Rahman S, Gupta PC, He J, Tsugane S, Xiang YB, Gao YT, Koh WP, Tamakoshi A, Irie F, Sadakane A, Tsuji I, Kanemura S, Matsuo K, Nagata C, Chen CJ, Yuan JM, Shin MH, Park SK, Pan WH, Qiao YL, Pednekar MS, Gu D, Sawada N, Li HL, Gao J, Cai H, Grant E, Tomata Y, Sugawara Y, Ito H, Wada K, Shen CY, Wang R, Ahn YO, You SL, Yoo KY, Ashan H, Chia KS, Boffetta P, Inoue M, Kang D, Potter JD, Zheng W. Tobacco Smoking and Mortality in Asia: A Pooled Meta-analysis. JAMA Netw Open, 2019 Mar 1;2(3):e191474. [PubMed

和文

      1. 片野田 耕太. 【肺癌 免疫・ゲノム医療で急展開する肺癌治療】 実地医家が知っておくべき肺癌診療の全体像 肺癌の疫学. Medical Practice, 36:190-195, 2019
      2. 片野田 耕太. 受動喫煙と健康被害. 法律のひろば, 72:11-16, 2019
      3. 齋藤 英子, 片野田 耕太. 第2章 医薬品市場・売上予測の手法と患者数予測の活用 第6節 がんの年齢階級別罹患数の将来予測. In: 医薬品マーケティングにおける市場・売上予測と戦略策定, 東京, 技術情報協会, 2019
      4. 片野田 耕太. 喫煙の疫学. In: 樋口 進, 廣 尚典, 「はたらく」を支える!職場×依存症・アディクション, 東京, 南山堂, 2019
      5. 片野田 耕太. 統計から見たがんのリスク層別の可能性. Gastro-Health Now, 60:1-3, 2019
      6. 片野田 耕太. In: 本当のたばこの話をしよう 毒なのか薬なのか, 東京, 日本評論社, 2019
      7. 片野田 耕太. 4. 福島県における「甲状腺検査」とがん登録. In: 安村 誠司, 福島原発事故における公衆衛生課題とその対応- 甲状腺検査と保健活動ー, 東京, 日本公衆衛生協会, 2019
      8. 片野田 耕太. 第4章 3. 胃がん生涯累積発生および死亡リスクの推定. In: 三木 一正, 胃がんリスク層別化検診(ABC検診)胃がんを予知・予防し,診断・治療するために, 東京, 南山堂, 2019
      9. 片野田 耕太. 第3章 4. 統計から見た胃がんリスク層別の可能性. In: 三木 一正, 胃がんリスク層別化検診(ABC検診)胃がんを予知・予防し,診断・治療するために, 東京, 南山堂, 2019
      10. 片野田 耕太, 風間 郁子. がんが怖くなくなるQ&A. In: NHKガッテン!, 東京, 主婦と生活社, pp 26-27, 2019

2018年

   英文

      1. Katanoda K. Japanese Legacy Cohorts: A New Series of Special Articles Has Started. J Epidemiol, 2018 Apr 5;28(4):161. [PubMed]
      2. Katanoda K, Hori M. Breast cancer incidence rates in the world from the Cancer Incidence in Five Continents XI. Jpn J Clin Oncol, 2018 Jul 1;48(7):701-702. [PubMed]
      3. Saito E, Katanoda K. Ovarian cancer incidence rates in the world from the Cancer Incidence in Five Continents XI. Jpn J Clin Oncol, 2018 May 1;48(5):501-502. [PubMed]
      4. Tanaka H, Ishikawa KB, Katanoda K. Geographic Access to Cancer Treatment in Japan: Results From a Combined Dataset of the Patient Survey and the Survey of Medical Institutions in 2011. J Epidemiol, 2018 Nov 5;28(11):470-475. [PubMed]
      5. Nakata K, Ito Y, Magadi W, Bonaventure A, Stiller CA, Katanoda K, Matsuda T, Miyashiro I, Pritchard-Jones K, Rachet B. Childhood cancer incidence and survival in Japan and England: A population-based study (1993-2010). Cancer Sci, 2018 Feb;109(2):422-434. [PubMed]
      6. Saito E, Hori M. Melanoma skin cancer incidence rates in the world from the Cancer Incidence in Five Continents XI. Jpn J Clin Oncol, 2018 Dec 1;48(12):1113-1114. [PubMed]
      7. Hori M, Saito E. Gallbladder cancer incidence rates in the world from the Cancer Incidence in Five Continents XI. Jpn J Clin Oncol, 2018 Sep 1;48(9):866-867. [PubMed]
      8. Otsuki S, Saito E, Sawada N, Abe SK, Hidaka A, Yamaji T, Shimazu T, Goto A, Iwasaki M, Iso H, Mizoue T, Shibuya K, Inoue M, Tsugane S. Female reproductive factors and risk of all-cause and cause-specific mortality among women: The Japan Public Health Center-based Prospective Study (JPHC study). Ann Epidemiol, 2018 ep;28(9):597-604.e6. [PubMed]
      9. Shin S, Saito E, Sawada N, Ishihara J, Takachi R, Nanri A, Shimazu T, Yamaji T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S. Dietary patterns and prostate cancer risk in Japanese: the Japan Public Health Center-based Prospective Study (JPHC Study). Cancer Causes Control, 2018 Jun;29(6):589-600. [PubMed]
      10. Narita S, Saito E, Sawada N, Shimazu T, Yamaji T, Iwasaki M, Ishihara J, Takachi R, Shibuya K, Inoue M, Tsugane S. Dietary consumption of antioxidant vitamins and subsequent lung cancer risk: The Japan Public Health Center-based prospective study. Int J Cancer, 2018 Jun 15;142(12):2441-2460. [PubMed]
      11. Swe KT, Rahman MM, Rahman MS, Saito E, Abe SK, Gilmour S, Shibuya K. Cost and economic burden of illness over 15 years in Nepal: A comparative analysis. PLoS ONE, 2018 Apr 4;13(4):e0194564. [PubMed]
      12. Narita S, Saito E, Sawada N, Shimazu T, Yamaji T, Iwasaki M, Sasazuki S, Noda M, Inoue M, Tsugane S. Coffee Consumption and Lung Cancer Risk: The Japan Public Health Center-Based Prospective Study. J Epidemiol, 2018 Apr 5;28(4):207-213. [PubMed]
      13. Shin S, Sawada N, Saito E, Yamaji T, Iwasaki M, Shimazu T, Sasazuki S, Inoue M, Tsugane S. Menstrual and reproductive factors in the risk of thyroid cancer in Japanese women: the Japan Public Health Center-Based Prospective Study. Eur J Cancer Prev, 2018 Jul;27(4):361-369. [PubMed]
      14. Shin S, Saito E, Sawada N, Ishihara J, Takachi R, Nanri A, Shimazu T, Yamaji T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S. Dietary patterns and colorectal cancer risk in middle-aged adults: A large population-based prospective cohort study. Clin Nutr, 2018 Jun;37(3):1019-1026. [PubMed]
      15. Saito E, Inoue M, Sawada N, Charvat H, Shimazu T, Yamaji T, Iwasaki M, Sasazuki S, Mizoue T, Iso H, Tsugane S. Impact of Alcohol Intake and Drinking Patterns on Mortality From All Causes and Major Causes of Death in a Japanese Population. J Epidemiol, 2018 Mar 5;28(3):140-148. [PubMed

和文

      1. 芽久美, 片野田 耕太. 肺癌の疫学. In: 三嶋 理晃, 高橋 和久, 呼吸器疾患診断治療アプローチ 肺癌, 東京, 中山書店, pp 2-4, 2018
      2. 渡辺 俊一, 大江 裕一郎, 堀之内 秀仁, 渡辺 裕一, 伊丹 純, 清水 研, 里見 絵里子, 八巻 智香子, 片野田 耕太, 吉見 逸郎, 若尾 文彦, 三石 一也, 国立がん研究センターの肺がんの本, 東京, 小学館クリエイティブ, pp 1-167, 2018
      3. 齋藤 英子, 片野田 耕太. 【動き始めたがんゲノム医療 深化と普及のための基礎研究課題】 (第1章)ゲノム医療の体制 現状と課題 ゲノム医療の経済評価における研究動向と課題. 実験医学, 36:2507-2512, 2018
      4. 片野田 耕太. 【喫煙関連疾患-予防と治療の最前線】 【喫煙の健康被害:最新情報】受動喫煙の健康被害. 医学のあゆみ, 265:855-859, 2018
      5. 片野田 耕太. 受動喫煙-分煙では防げない健康被害. 地方公務員安全と健康フォーラム, 107 6-11, 2018
      6. 片野田 耕太, 芽久美, 齋藤 英子. 国および都道府県のがん75歳未満年齢調整死亡率の予測値. JACR Monograph, 24:54-55, 2018
      7. 金光 幸秀, 朴 成和, 齋藤 豊, 松田 尚久, 角川 康夫, 清水 研, 里見 絵里子, 八巻 智香子, 櫻井 雅代, 片野田 耕太, 斎藤 博, 若尾 文彦, 国立がん研究センターの大腸がんの本, 東京, 小学館クリエイティブ, 2018
      8. 木下 貴之, 田村 研治, 清水 千佳子, 宮本 慎平, 高橋 加奈, 清水 研, 里見 絵里子, 斎藤 博, 八巻 智香子, 片野田 耕太, 若尾 文彦, 国立がん研究センターの乳がんの本, 東京, 小学館クリエイティブ, 2018
      9. 片井 均, 朴 成和, 小田 一郎, 清水 研, 里見 絵里子, 八巻 智香子, 櫻井 雅代, 片野田 耕太, 若尾 文彦, 国立がん研究センターの胃がんの本, 東京, 小学館クリエイティブ, 2018
      10. 島田 和明, 奥坂 拓志, 池田 公史, 秋元 哲夫, 清水 研, 里見 絵里子, 八巻 智香子, 片野田 耕太, 若尾 文彦, 国立がん研究センターの肝・胆・膵がんの本, 東京, 小学館クリエイティブ, 2018

2017年 

英文

      1. Katanoda K, Hori M. Incidence rate for gallbladder cancer in Japanese in Japan and in the United States from the Cancer Incidence in FiveContinents. Jpn J Clin Oncol, 2017 Feb 9;47(2):187-188. [PubMed]
      2. Katanoda K, Shibata A, Matsuda T, Hori M, Nakata K, Narita Y, Ogawa C, Munakata W, Kawai A, Nishimoto H. Childhood, adolescent and young adult cancer incidence in Japan in 2009-2011. Jpn J Clin Oncol, 2017 Aug 1;47(8):762-771. [PubMed]
      3. Katanoda K, Noda M, Goto A, Mizunuma H, Lee JS, Hayashi K. Impact of birth weight on adult-onset diabetes mellitus in relation to current body mass index: The Japan Nurses' Health Study. J Epidemiol, 2017 Sep;27(9):428-434. [PubMed]
      4. Hori M, Katanoda K. Incidence rate for melanoma of skin cancer in Japanese in Japan and in the United States from the Cancer Incidence in Five Continents. Jpn J Clin Oncol, 2017 Apr 1;47(4):373-374. [PubMed]
      5. Katanoda K, Hori M. The estimates of 5-year lung cancer prevalence in adult population in 2012. Jpn J Clin Oncol, 2017 Sep 1;47(9):896-897. [PubMed]
      6. Hori M, Katanoda K. The estimates of 5-year breast cancer prevalence in adult population in 2012. Jpn J Clin Oncol, 2017 Oct 1;47(10):993-994. [PubMed]
      7. Sado J, Kitamura T, Kitamura Y, Sobue T, Nishino Y, Tanaka H, Nakayama T, Tsuji I, Ito H, Suzuki T, Katanoda K, Tominaga S. Association between coffee consumption and all-sites cancer incidence and mortality. Cancer Sci, 2017 Oct;108(10):2079-2087. [PubMed]
      8. Shinagawa T, Kitamura T, Katanoda K, Matsuda T, Ito Y, Sobue T. The incidence and mortality rates of neuroblastoma cases before and after the cessation of the mass screening program in Japan: A descriptive study. Int J Cancer, 2017 Feb 1;140(3):618-625. [PubMed]
      9. Sado J, Kitamura T, Kitamura Y, Zha L, Liu R, Sobue T, Nishino Y, Tanaka H, Nakayama T, Tsuji I, Ito H, Suzuki T, Katanoda K, Tominaga S. Rationale, design, and profile of the Three-Prefecture Cohort in Japan: A 15-year follow-up. J Epidemiol, 2017 Apr;27(4):193-199. [PubMed]
      10. Chen Y, Wu F, Saito E, Lin Y, Song M, Luu HN, Gupta PC, Sawada N, Tamakoshi A, Shu XO, Koh WP, Xiang YB, Tomata Y, Sugiyama K, ParkSK, Matsuo K, Nagata C, Sugawara Y, Qiao YL, You SL, Wang R, Shin MH, Pan WH, Pednekar MS, Tsugane S, Cai H, Yuan JM, Gao YT, Tsuji I,Kanemura S, Ito H, Wada K, Ahn YO, Yoo KY, Ahsan H, Chia KS, Boff etta P, Zheng W, Inoue M, Kang D, Potter JD. Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium. Diabetologia, 2017 Jun;60(6):1022-1032. [PubMed]
      11. Narita S, Inoue M, Saito E, Abe SK, Sawada N, Ishihara J, Iwasaki M, Yamaji T, Shimazu T, Sasazuki S, Shibuya K, Tsugane S. Dietary fiber intake and risk of breast cancer defined by estrogen and progesterone receptor status: the Japan Public Health Center-based Prospective Study. Cancer Causes Control, 2017 Jun;28(6):569-578. [PubMed]
      12. Teng Y, Saito E, Abe SK, Sawada N, Iwasaki M, Yamaji T, Shimazu T, Sasazuki S, Inoue M, Tsugane S. Female reproductive factors,exogenous hormone use, and pancreatic cancer risk: the Japan Public Health Center-based prospective study. Eur J Cancer Prev, 2017 Sep;26(5):378-384. [PubMed]
      13. Nomura S, Sakamoto H, Glenn S, Tsugawa Y, Abe SK, Rahman MM, Brown JC, Ezoe S, Fitzmaurice C, Inokuchi T, Kassebaum NJ, KawakamiN, Kita Y, Kondo N, Lim SS, Maruyama S, Miyata H, Mooney MD, Naghavi M, Onoda T, Ota E, Otake Y, Roth GA, Saito E, Tabuchi T, TakasakiY, Tanimura T, Uechi M, Vos T, Wang H, Inoue M, Murray CJL, Shibuya K. Population health and regional variations of disease burden inJapan, 1990-2015: a systematic subnational analysis for the Global Burden of Disease Study 2015. Lancet, 2017 Sep 23;390(10101):1521-1538. [PubMed]
      14. Song H, Saito E, Sawada N, Abe SK, Hidaka A, Shimazu T, Yamaji T, Goto A, Iwasaki M, Sasazuki S, Ye W, Inoue M, Tsugane S. Body massindex change during adulthood and risk of oesophageal squamous-cell carcinoma in a Japanese population: the Japan Public Health (JPHC)-based prospective study. Br J Cancer, 2017 Nov 21;117(11):1715-1722. [PubMed]
      15. Taniyama Y, Katanoda K, Charvat H, Hori M, Ohno Y, Sasazuki S, Tsugane S. Estimation of lifetime cumulative incidence and mortality risk ofgastric cancer. Jpn J Clin Oncol, 2017 Nov 1;47(11):1097-1102. [PubMed]
      16. Song H, Saito E, Sawada N, Abe SK, Hidaka A, Shimazu T, Yamaji T, Goto A, Iwasaki M, Sasazuki S, Ye W, Inoue M, Tsugane S. Perceivedstress level and risk of cancer incidence in a Japanese population: the Japan Public Health Center (JPHC)-based Prospective Study. Sci Rep, 2017 11;7(1):12964. [PubMed]
      17. Saito E, Inoue M, Tsugane S, Ito H, Matsuo K, Wakai K, Wada K, Nagata C, Tamakoshi A, Sugawara Y, Tsuji I, Mizoue T, Tanaka K, SasazukiS. Smoking cessation and subsequent risk of cancer: A pooled analysis of eight population-based cohort studies in Japan. Cancer Epidemiol, 2017 Dec;51:98-108. [PubMed]

和文

    1. 片野田 耕太. 【がんの予防は可能か】 罹患・死亡統計からみたがんの予防可能性. 医学のあゆみ, 261:851-855, 2017
    2. 井上 真奈美, 齋藤 英子. 【がん転移学(上)-がん転移のメカニズムと治療戦略:その基礎と臨床-】 がんの疫学 アジアコホートコンソーシアム研究からみた生活習慣とがんリスク. 日本臨床, 75:91-96, 2017
    3. 片野田 耕太. 受動喫煙ってなんですか? 保健体育教室, 304 17-21, 2017
    4. 片野田 耕太. 喫煙による健康影響. 化学物質と環境, 142:6-8, 2017
    5. 片野田 耕太. 喫煙の健康影響とたばこ対策 第1回たばこ製品の現状. 中学保健ニュース, 4-5,12, 2017
    6. 片野田 耕太. 喫煙の健康影響とたばこ対策 第2回 たばこの健康影響. 中学保健ニュース, 4-5,12, 2017
    7. 片野田 耕太. 喫煙の健康影響とたばこ対策 第3回 たばこ対策. 中学保健ニュース, 4-5,12, 2017